Janus Henderson Group PLC Viking Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 45,700 shares of VKTX stock, worth $3.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,700
Previous 41,163
11.02%
Holding current value
$3.13 Million
Previous $3.38 Million
28.24%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VKTX
# of Institutions
480Shares Held
66.2MCall Options Held
6.24MPut Options Held
3.01M-
Vanguard Group Inc Valley Forge, PA10.1MShares$691 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$413 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$351 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$145 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$127 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.25B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...